Sol_75N95B26Q00015.pdf

75N95B26Q00015

1. REQUEST NO.

5a. ISSUED BY

NAME

a. NAME

c. STREET ADDRESS

d. CITY

10. PLEASE FURNISH QUOTATIONS TO

THE ISSUING OFFICE IN BLOCK 5a ON

OR BEFORE CLOSE OF BUSINESS (Date)

2. DATE ISSUED 3. REQUISITION/PURCHASE REQUEST NO. 4. CERT. FOR NAT. DEF.

UNDER BDSA REG. 2

AND/OR DMS REG.1

RATING

6. DELIVERY BY (Date)

7. DELIVERY

9. DESTINATION

a. NAME OF CONSIGNEE

b. STREET ADDRESS

PAGE OF PAGES

5b. FOR INFORMATION CALL: (No collect calls)

TELEPHONE NUMBER

AREA CODE NUMBER

8. TO:

b. COMPANY

e. STATE f. ZIP CODE

c. CITY

d. STATE e. ZIP CODE

IMPORTANT: This is a request for information, and quotations furnished are not offers. If you are unable to quote, please so indicate on this form and return it to the address in Block 5a. This request does not commit the Government to pay any costs incurred in the preparation of the submission of this quotation or to contract for supplies or services. Supplies are of domestic origin unless otherwise indicated by quoter. Any representations and/or certifications attached to this Request for Quotations must be completed by the quoter.

11. SCHEDULE (Include applicable Federal, State and local taxes)

THIS RFQ

REQUEST FOR QUOTATION

(THIS IS NOT AN ORDER)

IS IS NOT A SMALL BUSINESS SET ASIDEX

09/18/2026

1 1

OD - Office of Logistics and Acquisition Operations 6100 Executive Blvd., Room 6B05

National Institutes of Health

Bethesda, MD 20892-7511

Multiple

+10 000-000000BRITTANY MAY

09/28/2026 0900 ED

FOB DESTINATION

OTHER

(See Schedule)X

ITEM NO.

(a)

SUPPLIES/SERVICES

(b)

QUANTITY

(c)

UNIT

(d)

UNIT PRICE

(e)

AMOUNT

(f)

PCA-NIMH-05149

The purpose of this Non-Competitive Combined Synopsis/Solicitation is to procure Single-Cell Multiome ATAC + Gene Expression Sequencing Assay kits

12. DISCOUNT FOR PROMPT PAYMENT

a. 10 CALENDAR DAYS (%) b. 20 CALENDAR DAYS (%) c. 30 CALENDAR DAYS (%) d. CALENDAR DAYS

NUMBER PERCENTAGE

NOTE: Additional provisions and representations

13. NAME AND ADDRESS OF QUOTER

b. STREET ADDRESS

c. COUNTY

d. CITY e. STATE f. ZIP CODE

14. SIGNATURE OF PERSON AUTHORIZED TO

SIGN QUOTATION

16. SIGNER

a. NAME (Type or print)

c. TITLE (Type or print)

a. NAME OF QUOTER

AREA CODE

NUMBER

15. DATE OF QUOTATION

b. TELEPHONE are are not attached

AUTHORIZED FOR LOCAL REPRODUCTION

Previous edition not usable

STANDARD FORM 18 (REV. 6-95)

Prescribed by GSA - FAR (48 CFR) 53.215-1(a)

07/18

NON-COMPETITIVE COMBINED SYNOPSIS/SOLICITATION

INTRODUCTION

This is a non competitive combined synopsis/solicitation for commercial items prepared in accordance with FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued.

The solicitation number is 75N95B26Q00015. This solicitation is issued as a non-competitive combined synopsis/solicitation for commercial products or commercial services. The Government intends to award a contract or purchase order without providing for full and open competition (Including Brand-Name).

This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold.

The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to negotiate and award a Firm-Fixed Price Purchase Order on a non-competitive basis to 10X Genomics, inc. for Single-Cell Multiome ATAC + GEM Gene Expression Sequencing Assay kits.

NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE

The intended procurement is classified under NAICS code 334516 - Analytical Laboratory Instrument Manufacturing.

REGULATORY AUTHORITY

The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2026-01 effective March 13, 2026.

• This requirement is unrestricted

DESCRIPTION OF REQUIREMENT

The National Institute of Environmental Health Sciences, Experimental Therapeutics & Pathophysiology Branch uses RNA sequencing and epigenetic DNA methylation arrays with clinical blood RNA samples and neuronal cell culture samples to study the epigenetic state of chromatin in a certain biological context can shed light onto the molecular mechanisms underlying the observed gene expression patterns. To do so, the lab utilizes ATAC sequences to generate genome-wide regulatory maps, providing a simple and scalable way to assay the regions of the genome that are bound by TFs, and to compare how these landsacpes change between particular contexts or treatments.

The Experimental Therapeutics & Pathophysiology Branch requires Single-Cell Multiome ATAC + Gene Expression Sequencing Assay kits to define biomarkers of response to ketamine, on global epigenetic control of gene expression in cerebral organoids by utilizing high-throughput sequencing to analyze genome- wide chromatin accessibility and transcriptome gene expression profile in 8 human iPSC-derived cerebral organoids samples.

CONTRACTOR REQUIREMENTS

Contractor shall provide the following:

ITEM

NO.

SCHEDULE OF SERVICES QUANTITY UNIT UNIT PRICE TOTAL AMT

0001 Kit, RNase Inhibitor 40x 1 EA $ $

0002 Single Index Kit N Set A 1 EA $ $

0003 hromium Next GEM Single Cell Multiome ATAC + Gene Expression Reagent Bundle, 4 rxns

2 EA

0004 Chromium Next GEM Chip J Single Cell Kit, 16 rxns

1 EA $ $

0005 Dual Index Kit TT Set A, 96 rxn 1 EA $ $

TOTAL: $

EXPIRATION DATE OF QUOTE:

DELIVERY LOCATION

10CRC, Room 7-5342 10 Center Drive, MSC 1282 Bethesda, MD 20892

The provision at FAR 52.212-1, Instructions to Offerors—Commercial Items, applies to this acquisition. Add any agency-specific instructions as required.

The provision at FAR 52.212-2, Evaluation—Commercial Items, applies to this acquisition.

The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation represents the best value to the Government, price and other factors considered.

Evaluation Factors: (Customize as needed)

• Price

• Technical capability

• Past performance

• Delivery schedule (Include relative importance of factors if required.)

A written notice of award or acceptance of an offer, issued within the time specified in the offer, shall result in a binding contract without further action by either party. The Government reserves the right to accept any offer before the expiration date.

Offerors shall include a completed copy of FAR 52.212-3, Offeror Representations and Certifications—Commercial Items, with their offer.

FAR 52.212-4, Contract Terms and Conditions—Commercial Items, applies to this acquisition.

FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders—Commercial Items, applies to this acquisition.

Additional contract requirements or terms and conditions, as determined necessary by the Contracting Officer and consistent with customary commercial practices: None

The Defense Priorities and Allocations System (DPAS) is not applicable.

SUBMISSION REQUIREMENTS

This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this synopsis must include sufficient information to demonstrate the offeror’s bona-fide capabilities for fulfilling the required product or service. Responses must include, at a minimum:

• Unit and total price

• Shipping and handling costs

• Delivery period after award

• Delivery terms

• F.O.B. point (destination or origin)

• Product or catalog numbers (if applicable)

• Product/service description

Additional evaluation considerations may include past performance, warranty, lifecycle cost, maintenance availability, and environmental or energy efficiency.

Responses must include the Unique Entity Identifier (UEI), Taxpayer Identification Number (TIN), and business size certification. All offerors must be actively registered in the System for Award Management (SAM) at www.sam.gov.

All responses must be received by September 28, 2026 at 5:30 pm EDT and must reference solicitation number 75N95B26Q00015. Responses must be submitted via the SAM.gov webportal. Potential Offerors do not need to register to view a notice;

however, in order to submit questions and/or response to this Notice, an account will need to be established.

POINT OF CONTACT:

Brittany May Contract Specialist Brittany.may@nih.gov http://www.sam.gov/